St. Louis-based PierianDx, which provides a genomics SaaS platform for clinical labs to build personalized medicine programs, raises $27M Series B — The startup describes its software as providing clinical labs with more streamlined and accurate analysis, interpretation and reporting for accelerating personalized medicine programs.
No comments:
Post a Comment